Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news


MA fury over PBAC move

Posted 16 February 2021 PM

The Health Department's announcement of a much tighter 'use it or lose it' deadline for positive PBAC recommendations has been met with strong criticism from Medicines Australia, which is calling for it to be walked back.

Although the department said in announcing the change yesterday (Monday) that it had consulted with industry and "received written feedback", today's response from MA indicates the feedback was most likely ignored.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Approvals Action
Pfizer vs Humira
Adds to a growing list of adalimumab biosims
Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas